112 related articles for article (PubMed ID: 10951871)
1. [Sexual activity and the cardiovascular system in health and disease. Use of sildenafil in heart patients].
Kovác J; Mensa J
Vnitr Lek; 1999 Oct; 45(10):610-3. PubMed ID: 10951871
[TBL] [Abstract][Full Text] [Related]
2. Erectile dysfunction, sildenafil and cardiovascular risk.
Chew KK; Stuckey BG; Thompson PL
Med J Aust; 2000 Mar; 172(6):279-83. PubMed ID: 10860094
[TBL] [Abstract][Full Text] [Related]
3. [Sex, erectile dysfunction, and the heart: a growing problem].
Görge G; Flüchter S; Kirstein M; Kunz T
Herz; 2003 Jun; 28(4):284-90. PubMed ID: 12825143
[TBL] [Abstract][Full Text] [Related]
4. Sexual activity with and without the use of sildenafil: risk of cardiovascular events in patients with heart disease.
Alboni P; Bettiol K; Fucà G; Pacchioni F; Scarfò S
Ital Heart J; 2004 May; 5(5):343-9. PubMed ID: 15185897
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular safety of sildenafil citrate (Viagra): an updated perspective.
Jackson G; Montorsi P; Cheitlin MD
Urology; 2006 Sep; 68(3 Suppl):47-60. PubMed ID: 17011375
[TBL] [Abstract][Full Text] [Related]
6. Managing sexual dysfunction. Using sildenafil for patients with cardiovascular disease. Heart and Stroke Foundation of Canada. Canadian Cardiovascular Society.
Can Fam Physician; 2000 Feb; 46():393, 398. PubMed ID: 10690496
[No Abstract] [Full Text] [Related]
7. Comparison of trimetazidine plus sildenafil to chronic nitrates in the control of myocardial ischemia during sexual activity in patients with coronary artery disease.
Rosano GM; Marazzi G; Patrizi R; Cerquetani E; Vitale C; Volterrani M; Fini M; Mercuro G
Am J Cardiol; 2005 Feb; 95(3):327-31. PubMed ID: 15670539
[TBL] [Abstract][Full Text] [Related]
8. Sildenafil citrate for erectile dysfunction in men with diabetes and cardiovascular risk factors: a retrospective analysis of pooled data from placebo-controlled trials.
Blonde L
Curr Med Res Opin; 2006 Nov; 22(11):2111-20. PubMed ID: 17076971
[TBL] [Abstract][Full Text] [Related]
9. Acute myocardial infarction after sildenafil citrate ingestion.
Kekilli M; Beyazit Y; Purnak T; Dogan S; Atalar E
Ann Pharmacother; 2005; 39(7-8):1362-4. PubMed ID: 15914518
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular safety of PDE5 inhibitors.
Herschorn S
Can J Urol; 2003 Feb; 10 Suppl 1():23-8. PubMed ID: 12625847
[TBL] [Abstract][Full Text] [Related]
11. [Side effects of sildenafil: findings from two years practical experience].
van Grootheest AC; Straus SM; Heeringa M
Ned Tijdschr Geneeskd; 2001 Mar; 145(11):526-9. PubMed ID: 11284286
[TBL] [Abstract][Full Text] [Related]
12. A statement on the use of sildenafil in the management of sexual dysfunction in patients with cardiovascular disease. Heart and Stroke Foundation of Canada. Canadian Cardiovascular Society.
Can J Cardiol; 1999 Apr; 15(4):396-9. PubMed ID: 10348610
[No Abstract] [Full Text] [Related]
13. [The heart and sexual activity].
Douard H
Arch Mal Coeur Vaiss; 1999 Oct; 92(10):1331-5. PubMed ID: 10562903
[TBL] [Abstract][Full Text] [Related]
14. Efficacy, safety and patient acceptance of sildenafil citrate as treatment for erectile dysfunction.
McMahon CG; Samali R; Johnson H
J Urol; 2000 Oct; 164(4):1192-6. PubMed ID: 10992364
[TBL] [Abstract][Full Text] [Related]
15. [A decade's evidence review of sildenafil citrate].
Zhang K; Zhu JC
Zhonghua Nan Ke Xue; 2009 Jan; 15(1):3-6. PubMed ID: 19288739
[TBL] [Abstract][Full Text] [Related]
16. Use of sildenafil is safe in men with congestive heart failure.
Mickley H; Poulsen TS
Arch Intern Med; 2004 Oct; 164(18):2068. PubMed ID: 15477451
[No Abstract] [Full Text] [Related]
17. Erectile dysfunction in patients with coronary artery disease.
Kloner R; Padma-Nathan H
Int J Impot Res; 2005; 17(3):209-15. PubMed ID: 15729374
[TBL] [Abstract][Full Text] [Related]
18. [Myocardial ischemia after administration de sildenafil: description of a case and review of the literature].
Piccoli M; De Santis LM
Ital Heart J Suppl; 2000 Sep; 1(9):1196-8. PubMed ID: 11140290
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study.
Eardley I; Montorsi F; Jackson G; Mirone V; Chan ML; Loughney K; Vail GM; Beardsworth A
BJU Int; 2007 Jul; 100(1):122-9. PubMed ID: 17552960
[TBL] [Abstract][Full Text] [Related]
20. Reasons for discontinuation of sildenafil citrate after successful restoration of erectile function.
Son H; Park K; Kim SW; Paick JS
Asian J Androl; 2004 Jun; 6(2):117-20. PubMed ID: 15154085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
